Key regions: United Kingdom, Canada, Japan, Europe, China
The demand for dermatological drugs in Croatia has been on the rise in recent years, driven by several factors including changing customer preferences and local special circumstances.
Customer preferences: Croatian consumers have become increasingly health-conscious and are more willing to invest in products that promote healthy skin. This has led to a growing demand for dermatological drugs that treat a range of skin conditions, including acne, eczema, and psoriasis. Additionally, there has been a shift towards natural and organic products, with many consumers seeking out products that are free from harsh chemicals and preservatives.
Trends in the market: One of the key trends in the dermatological drugs market in Croatia is the growing popularity of topical treatments. These products are easy to apply and can be used to treat a range of skin conditions, from mild to severe. Another trend is the increasing use of combination therapies, which combine two or more drugs to provide more effective treatment. This approach is particularly effective in treating chronic skin conditions such as psoriasis.
Local special circumstances: Croatia's sunny climate and proximity to the sea mean that many people spend a lot of time outdoors. This has led to a high incidence of skin cancer and other sun-related skin conditions, which has driven demand for dermatological drugs that protect against UV radiation. Additionally, Croatia has a large elderly population, and as people age, they are more likely to develop skin conditions such as eczema and psoriasis.
Underlying macroeconomic factors: Croatia's economy has been growing steadily in recent years, which has led to an increase in disposable income. This has enabled consumers to invest more in their health and wellbeing, including their skin health. Additionally, Croatia's accession to the EU in 2013 has led to increased competition in the healthcare sector, which has driven down prices and made dermatological drugs more affordable for consumers. Finally, Croatia's healthcare system is well-developed, with a strong network of hospitals and clinics that provide high-quality care to patients with skin conditions. This has helped to drive demand for dermatological drugs as patients seek out effective treatments for their skin conditions.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
